

The Lymphoma Sessions: highlights from ASH 2020
Mar 17, 2021
Leading experts discuss highlights from ASH 2020, including bi-specific antibody therapies, management of CNS involvement, Vipa regimen benefits and cost comparison with CAR-T therapy, transplantation options and outcomes, and drug combinations, response rates, and precision medicine in lymphoma treatment.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 3min
Bi-specifics: Design, Administration, and Durability
03:12 • 4min
Management of CNS Involvement in Lymphoma Patients
07:09 • 7min
Vipa regimen and cost comparison with CAR-T therapy
13:56 • 5min
Transplantation Options and Outcomes in Lymphoma Treatment
19:00 • 11min
Discussion on Drug Combinations, Response Rates, and Precision Medicine in Lymphoma Treatment
30:21 • 5min